Shinji Kobuchi Selected Research

arbekacin

6/2022	Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant Staphylococcus aureus agents using a rat model of sepsis.
1/2021	Comparison of In Vivo Transportability of Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents Into Intracellular and Extracellular Tissue Spaces in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinji Kobuchi Research Topics

Disease

13	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2013
5	Neoplasms (Cancer) 02/2020 - 01/2013
4	Type 2 Diabetes Mellitus (MODY) 02/2022 - 08/2016
3	Infections 01/2021 - 11/2016
2	Sepsis (Septicemia) 06/2022 - 05/2020
2	Body Weight (Weight, Body) 02/2022 - 08/2017
2	Hyperalgesia 09/2020 - 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 12/2021
1	Renal Insufficiency (Renal Failure) 12/2021
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Dyslipidemias (Dyslipidemia) 05/2020
1	Inflammation (Inflammations) 05/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Esophageal Squamous Cell Carcinoma 01/2019
1	Skin Diseases (Skin Disease) 01/2018
1	Hypersensitivity (Allergy) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Obesity 03/2013
1	Hyperlipidemias (Hyperlipidemia) 11/2009

Drug/Important Bio-Agent (IBA)

12	Fluorouracil (Carac)FDA LinkGeneric 03/2021 - 01/2013
6	Pharmaceutical PreparationsIBA 06/2022 - 08/2017
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 01/2018
5	SodiumIBA 02/2022 - 08/2016
5	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 08/2016
5	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2018
4	ProdrugsIBA 03/2021 - 01/2018
4	UracilIBA 10/2018 - 01/2013
4	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 10/2013 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 10/2013 - 01/2013
3	dihydrouracilIBA 10/2013 - 01/2013
2	arbekacinIBA 06/2022 - 01/2021
2	Vancomycin FDA LinkGeneric 06/2022 - 01/2021
2	SymportersIBA 02/2022 - 01/2018
2	AcetoneIBA 09/2020 - 01/2018
2	Azithromycin (Zithromax)FDA LinkGeneric 05/2020 - 11/2016
2	PlatinumIBA 02/2020 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 02/2020 - 01/2015
2	Atazanavir Sulfate (Reyataz)FDA Link 03/2013 - 11/2009
1	Linezolid (Zyvox)FDA Link 06/2022
1	Daptomycin FDA Link 06/2022
1	Anti-Infective Agents (Microbicides)IBA 06/2022
1	Metformin (Glucophage)FDA LinkGeneric 02/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2022
1	dapagliflozinIBA 02/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2020
1	Erythromycin (Erycette)FDA LinkGeneric 05/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 05/2020
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 05/2020
1	MacrolidesIBA 05/2020
1	AfatinibIBA 12/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	TegafurIBA 10/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2017
1	polyarginineIBA 01/2017
1	CanagliflozinIBA 10/2016
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 08/2016

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Drug Tapering 12/2021 - 08/2019
1	Punctures 06/2022
1	Ligation 06/2022
1	Transplantation 12/2020
1	Intraperitoneal Injections 12/2020
1	Chemoradiotherapy 01/2019
1	Aftercare (After-Treatment) 01/2019
1	Adjuvant Chemotherapy 10/2018
1	Intravenous Administration 08/2017